Ascentage Pharma Group International
General ticker "ASPHF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.4B (TTM average)
Ascentage Pharma Group International does not follow the US Stock Market performance with the rate: -42.6%.
Estimated limits based on current volatility of 0.0%: low 3.46$, high 3.46$
Short-term ASPHF quotes
Long-term ASPHF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | CNY221.98MM | CNY980.65MM |
| Operating Expenses | CNY1,094.62MM | CNY1,350.38MM |
| Operating Income | CNY-872.64MM | CNY-369.73MM |
| Non-Operating Income | CNY-60.23MM | CNY-25.52MM |
| Interest Expense | CNY96.06MM | CNY64.45MM |
| R&D Expense | CNY706.97MM | CNY947.25MM |
| Income(Loss) | CNY-932.86MM | CNY-395.25MM |
| Taxes | CNY-7.15MM | CNY10.43MM |
| Net Income(Loss)* | CNY-925.64MM | CNY-405.43MM |
| Stockholders Equity | CNY60.42MM | CNY264.19MM |
| Inventory | CNY16.17MM | CNY6.60MM |
| Assets | CNY2,500.39MM | CNY2,617.81MM |
| Operating Cash Flow | CNY-726.08MM | CNY-111.36MM |
| Capital expenditure | CNY56.84MM | CNY24.29MM |
| Investing Cash Flow | CNY21.92MM | CNY-362.04MM |
| Financing Cash Flow | CNY368.75MM | CNY314.77MM |
| Earnings Per Share** | CNY-3.28 | CNY-1.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.